首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1513774

全球先進輸液系統市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Advanced Infusion Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球先進輸液系統市場需求預計將從 2023 年的 84.4 億美元達到 2032 年近 178.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.68%。

先進的輸液系統是用於以受控方式將藥物、營養素和血液製品等液體直接輸送到患者血液中的醫療設備。這些系統包括可程式輸液幫浦、智慧靜脈注射 (IV) 裝置以及用於監測和調節流量的軟體。它們透過確保準確劑量、降低用藥錯誤風險並允許精確控制輸液治療來增強患者護理。這些系統在各種臨床環境中至關重要，包括醫院、門診診所和家庭護理。

市場動態

先進輸液系統市場是由慢性疾病負擔不斷增加以及對精確和受控藥物輸送方法不斷成長的需求所推動的。隨著糖尿病、癌症和心血管疾病等疾病發生率的上升，對有效輸注療法的需求變得更加迫切。先進的輸液系統具有顯著的準確性、安全性和病患舒適度，使其在現代醫療保健環境中不可或缺。輸液泵的技術進步，例如開發具有整合即時監控和調整軟體的智慧泵，進一步推動了市場成長。人口老化以及隨後與年齡相關的健康狀況的增加也促進了市場成長。

向家庭醫療保健和門診護理服務的轉變也促進了攜帶式和方便用戶使用型輸液設備的採用。政府的措施和有利的輸液治療報銷政策對於促進市場成長至關重要。此外，對改善醫療基礎設施的日益關注以及醫療保健提供者和患者對先進輸液技術益處的認知不斷增強，推動了市場向前發展。然而，先進輸液系統的高成本以及對醫療保健專業人員進行全面培訓的要求可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球先進輸液系統市場的每個細分市場進行了包容性評估。先進輸液系統產業的成長和趨勢為本研究提供了整體方法。

市場區隔

先進輸液系統市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

病人自控鎮痛泵
容量輸液系統
注射器輸液系統
門診輸液系統
一次性輸液系統
彈性體輸注系統
植入式輸液系統

按申請

糖尿病
氣喘
化療
疼痛管理
臨床營養

按最終用戶

門診手術中心
床頭
醫院
診斷中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲先進輸液系統市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。先進輸液系統市場的主要參與者包括 Hospira Inc.、Animas Corporation、Terumo Corporation、F.Hoffmann-La Roche Ltd.、AngioDynamics Inc.、B.Braun Melsungen AG。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：先進輸液系統公司的競爭格局

先進輸液系統市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Hospira Inc.

公司簡介
公司收入
產品
最近的發展

Animas Corporation

公司簡介
公司收入
產品
最近的發展

Terumo Corporation

公司簡介
公司收入
產品
最近的發展

F.Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

AngioDynamics Inc.

公司簡介
公司收入
產品
最近的發展

B.Braun Melsungen AG

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115067

The global demand for Advanced Infusion Systems Market is presumed to reach the market size of nearly USD 17.85 Billion by 2032 from USD 8.44 Billion in 2023 with a CAGR of 8.68% under the study period 2024-2032.

Advanced infusion systems are medical devices used to deliver fluids, such as medications, nutrients, and blood products, directly into a patient's bloodstream in a controlled manner. These systems include programmable infusion pumps, smart intravenous (IV) sets, and software for monitoring and adjusting flow rates. They enhance patient care by ensuring accurate dosing, reducing the risk of medication errors, and allowing for precise control of infusion therapy. These systems are vital in various clinical settings, including hospitals, outpatient clinics, and home care.

MARKET DYNAMICS

The advanced infusion systems market is driven by the rising burden of chronic diseases and the growing demand for precise and controlled drug delivery methods. As the incidence of conditions like diabetes, cancer, and cardiovascular diseases rises, the need for effective infusion therapies becomes more critical. Advanced infusion systems offer significant accuracy, safety, and patient comfort benefits, making them indispensable in modern healthcare settings. Technological advancements in infusion pumps, such as developing smart pumps with integrated real-time monitoring and adjustment software, further drive market growth. The aging population and the subsequent increase in age-related health conditions also contribute to the rising market growth.

The shift towards home healthcare and outpatient care services also boosts the adoption of portable and user-friendly infusion devices. Government initiatives and favorable reimbursement policies for infusion therapies are crucial in promoting market growth. Moreover, the increasing focus on improving healthcare infrastructure and the growing awareness about the benefits of advanced infusion technologies among healthcare providers and patients drive the market forward. However, the high cost of advanced infusion systems and the requirement for thorough training of healthcare professionals may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Advanced Infusion Systems. The growth and trends of Advanced Infusion Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Advanced Infusion Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Patient-Controlled Analgesia Pump
Volumetric Infusion System
Syringe Infusion System
Ambulatory Infusion System
Disposable Infusion System
Elastomeric Infusion System
Implantable Infusion System

By Application

Diabetes
Asthma
Chemotherapy
Pain Management
Clinical Nutrition

By End-User

Ambulatory Surgical Centers
Bedside
Hospitals
Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Advanced Infusion Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Advanced Infusion Systems market include Hospira Inc., Animas Corporation, Terumo Corporation, F.Hoffmann-La Roche Ltd., AngioDynamics Inc., B.Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ADVANCED INFUSION SYSTEMS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Patient-Controlled Analgesia Pump Historic and Forecast Sales By Regions
5.4. Volumetric Infusion System Historic and Forecast Sales By Regions
5.5. Syringe Infusion System Historic and Forecast Sales By Regions
5.6. Ambulatory Infusion System Historic and Forecast Sales By Regions
5.7. Disposable Infusion System Historic and Forecast Sales By Regions
5.8. Elastomeric Infusion System Historic and Forecast Sales By Regions
5.9. Implantable Infusion System Historic and Forecast Sales By Regions

6. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Diabetes Historic and Forecast Sales By Regions
6.4. Asthma Historic and Forecast Sales By Regions
6.5. Chemotherapy Historic and Forecast Sales By Regions
6.6. Pain Management Historic and Forecast Sales By Regions
6.7. Clinical Nutrition Historic and Forecast Sales By Regions

7. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.4. Bedside Historic and Forecast Sales By Regions
7.5. Hospitals Historic and Forecast Sales By Regions
7.6. Diagnostic Centers Historic and Forecast Sales By Regions

8. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADVANCED INFUSION SYSTEMS COMPANIES

9.1. Advanced Infusion Systems Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ADVANCED INFUSION SYSTEMS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Hospira Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Animas Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Terumo Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F.Hoffmann-La Roche Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. AngioDynamics Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. B.Braun Melsungen AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments